13F Holdings
中文EN

AFJK Aimei Health Technology Co., Ltd.

Blank Checks · Nasdaq · SEC CIK 1979005 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY-97.9%
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE—
ROA0.1%
ROIC (approx.)—
Asset turnover—

Leverage & solvency

Liabilities / assets37.7%
Debt / equity—
Current ratio0.01x
Interest coverage—

Cash quality & payout

Operating cash flow / net income-21.01x
Accruals ratio2.2%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31
Income statement
Revenue———
Operating income-$835,759-$1.06M—
Income tax$0$0$0
Net income$1.06M$2.55M—
EPS (diluted)———
Balance sheet
Cash & equivalents$2,929$28,208$580,717
Current assets$2,929$30,384$580,717
Total assets$12.10M$73.81M$70.47M
Current liabilities$3.37M$816,994$24,841
Total liabilities$4.06M$1.51M$714,841
Shareholders' equity-$4.06M-$1.48M-$134,124
Shares outstanding2.13M2.13M2.13M
Cash flow statement
Operating cash flow-$565,100-$672,289—
Investing cash flow$63.58M-$277,700—
Financing cash flow-$63.04M$397,480—

· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".

· This company reports EPS only by share class (e.g. class A/B), so it is shown as —.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.